38474412|t|Proximity-Induced Pharmacology for Amyloid-Related Diseases.
38474412|a|Proximity-induced pharmacology (PIP) for amyloid-related diseases is a cutting-edge approach to treating conditions such as Alzheimer's disease and other forms of dementia. By bringing small molecules close to amyloid-related proteins, these molecules can induce a plethora of effects that can break down pathogenic proteins and reduce the buildup of plaques. One of the most promising aspects of this drug discovery modality is that it can be used to target specific types of amyloid proteins, such as the beta-amyloid protein that is commonly associated with Alzheimer's disease. This level of specificity could allow for more targeted and effective treatments. With ongoing research and development, it is hoped that these treatments can be refined and optimized to provide even greater benefits to patients. As our understanding of the underlying mechanisms of these diseases continues to grow, proximity-induced pharmacology treatments may become an increasingly important tool in the fight against dementia and other related conditions.
38474412	35	59	Amyloid-Related Diseases	Disease	MESH:C000718787
38474412	102	126	amyloid-related diseases	Disease	MESH:C000718787
38474412	185	204	Alzheimer's disease	Disease	MESH:D000544
38474412	224	232	dementia	Disease	MESH:D003704
38474412	622	641	Alzheimer's disease	Disease	MESH:D000544
38474412	863	871	patients	Species	9606
38474412	1065	1073	dementia	Disease	MESH:D003704

